Novagenix conduct the clinical trials in Hakan Cetinsaya IKU Center, Erciyes University School of Medicine, Kayseri.

  Study protocol that is written according to the GCP and Turkish Ministry of Health’s requirements is submitted to Ethical Committtee (EC) of the university. After getting the approval of EC, the study is started, conducted and completed according to the timetable which is made by the investigator.

 All tubes for blood samplings, test and reference drug products and other materials (CRFs, labels, timetables, boxes, etc.) are sent to the investigator before the beginning of the study.

 All participants are insured by Novagenix.

 The study consist of two run-in period and a washout period. After drawing, all blood samples (plasma or serum) are put into -70°C deep-freezers until shipment. Master and back-up samples are sent to Novagenix in different days and transportations is achieved in maximum 24 hours.

Once master samples are reached Novagenix, analytical phase of project is started.